Therapeutics

Monopar Therapeutics Stock Hits 52-Week High at $38.91 By Investing.com

by
Monopar Therapeutics Stock Hits 52-Week High at $38.91 By Investing.com

Monopar Therapeutics Inc . (NASDAQ: ) stock rose to a 52-week high at $38.91. The company, currently valued at $200 million, has analyst price targets of $37 to $72, according to InvestingPro. This milestone marks a significant period of growth for the company, which has seen its share price skyrocket over the past year. Investors … Read more

Edgewise Therapeutics chief scientific officer sells $2.74 million in stock By Investing.com

by
Edgewise Therapeutics chief scientific officer sells $2.74 million in stock By Investing.com

Russell Allan J, Chief Scientific Officer of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) recently made a significant sell in the stock. On December 30, 2024, Russell sold 100,000 shares of common stock, earning approximately $2.74 million. The stock was sold at an average price of $27.37, with transactions taking place in a price range of $20.00 to … Read more

Kuehn Law Encourages Investors of Akero Therapeutics, Inc. to Contact Law Firm By Investing.com

by
Kuehn Law Encourages Investors of Akero Therapeutics, Inc. to Contact Law Firm By Investing.com

NEW YORK, NY–(Newsfile Corp. – December 30, 2024) – Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors Akero Therapeutics, Inc. (NASDAQ: NASDAQ:) breached their fiduciary duties to shareholders. The investigation concerns potential self-employment. Shareholders may have rights to damages and corporate governance reforms. if you are long term … Read more

Vera Therapeutics CEO sells shares worth over $821k By Investing.com

by
Vera Therapeutics CEO sells shares worth over $821k By Investing.com

BRISBANE, Calif. — Fordyce Marshall, president and CEO of Vera Therapeutics Inc. (NASDAQ:VERA), recently completed a series of stock transactions, according to a filing with the Securities and Exchange Commission. On December 11th, Marshall sold 17,500 shares of Class A common stock, netting approximately $821,523. Shares were traded at prices ranging from $46.9112 to $47.65. … Read more